Publications

Killer ILCs in the Fat

Narni-Mancinelli E, Vivier E., Immunity, 2017, 46(2):169-171, PMID: 28228274

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

Rusakiewicz S, Perier A, Semeraro M, Pitt JM, Pogge von Strandmann E, Reiners KS, Aspeslagh S, Pipéroglou C, Vély F, Ivagnes A, Jegou S, Halama N, Chaigneau L, Validire P, Christidis C, Perniceni T, Landi B, Berger A, Isambert N, Domont J, Bonvalot S, Terrier P, Adam J, Coindre JM, Emile JF, Poirier-Colame V, Chaba K, Rocha B, Caignard A, Toubert A, Enot D, Koch J, Marabelle A, Lambert M, Caillat-Zucman S, Leyvraz S, Auclair C, Vivier E, Eggermont A, Borg C, Blay JY, Le Cesne A, Mir O, Zitvogel L., Oncoimmunology, 2017, 6(1):e1137418, PMID: 28197361

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival

Charlotte Viant, Sophie Guia, Robert J. Hennessy, Jai Rautela, Kim Pham, Claire Bernat, Wilford Goh, Yuhao Jiao, Rebecca Delconte, Michael Roger, Vanina Simon, Fernando Souza-Fonseca-Guimaraes, Stephanie Grabow, Gabrielle T. Belz, Benjamin T. Kile, Andreas Strasser, Daniel Gray, Phillip D. Hodgkin, Bruce Beutler, Eric Vivier, Sophie Ugolini, Nicholas D. Huntington, J Exp Med., 2017, DOI: 10.1084/jem.20160869

Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils

Malbec O, Cassard L, Albanesi M, Jönsson F, Mancardi D, Chicanne G, Payrastre B, Dubreuil P, Vivier E, Daëron M., Sci Signal., 2016, 9(459):ra126, PMID: 27999175

Corrigendum: Evidence of innate lymphoid cell redundancy in humans

Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, Blanche S, Dujardin A, Spits H, Distler JH, Ramming A, Picard C, Golub R, Fischer A, Vivier E., Nat Immunol., 2016, 17(12):1479, PMID: 27849206

Manufacturing Natural Killer Cells as Medicinal Products

Chabannon C, Mfarrej B, Guia S, Ugolini S, Devillier R, Blaise D, Vivier E, Calmels B., Front Immunol., 2016, 7:504, PMID: 27895646

PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma

Beldi-Ferchiou A, Lambert M, Dogniaux S, Vély F, Vivier E, Olive D, Dupuy S, Levasseur F, Zucman D, Lebbé C, Sène D, Hivroz C, Caillat-Zucman S., Oncotarget, 2016, doi: 10.18632, PMID: 27662664

Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30

Xu X, Narni-Mancinelli E, Cantoni C, Li Y, Guia S, Gauthier L, Chen Q, Moretta A, Vély F, Eisenstein E, Rangarajan S, Vivier E, Mariuzza RA., J Mol Biol., 2016, (16)30375-8, PMID: 27663271

Evidence of innate lymphoid cell redundancy in humans

Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, Blanche S, Dujardin A, Spits H, Distler JH, Ramming A, Picard C, Golub R, Fischer A, Vivier E., Nat Immunol., 2016, doi: 10.1038/ni.3553, PMID: 27618553

HLA-Fatal attraction

Vély F, Golub R, Vivier E., Nat Immunol., 2016, 17(9):1012-4, PMID: 27540985